Beyond Air® Prepares for Financial Results Announcement
Beyond Air, Inc. (NASDAQ: XAIR), a pioneering company in the medical technology sector, has announced its intention to report its financial results for the second quarter of fiscal year 2025, which concluded on September 30, shortly after the market closes on November 11, 2024. This event highlights Beyond Air's continuous commitment to transparency and shareholder engagement.
Details of the Conference Call and Webcast
As part of this financial report announcement, Beyond Air will host a conference call at 4:30 PM ET on the same day. Stakeholders and interested parties can join the call through the following numbers:
Domestic and International Calling Information
For those within the United States, the toll-free number is 1-877-407-0784. International callers can connect via 1-201-689-8560. Participants will be asked to reference Conference ID: 13749670.
Accessing the Webcast
A live webcast of the conference call will also be available. You can find this on the company’s official website under the Events section or by using the provided direct link. An online replay of the call will be accessible approximately one hour after its conclusion, ensuring that all interested stakeholders can stay informed.
The Innovative Mission of Beyond Air
Beyond Air, Inc. is committed to revolutionizing lung disease treatments through its advanced technologies. The company focuses on the LungFit® platform, which is designed to generate and deliver nitric oxide (NO) in a safe and effective manner. This technology serves a broad spectrum of respiratory issues, ranging from neonatal needs to conditions affecting adults.
How LungFit® Enhances Patient Care
The LungFit® platform not only improves the therapeutic potential for numerous respiratory conditions but does so while simplifying the logistics of NO delivery. By mitigating the need for cumbersome storage and transport of NO, Beyond Air’s devices enhance patient safety and operational efficiency in healthcare settings.
Recent Developments and Strategic Goals
Beyond Air's strategic initiatives align with its commitment to introducing innovative healthcare solutions. As the company prepares for the upcoming financial results, a focus on research and development continues to shape its long-term goals. Investing in the future of lung health is paramount, as Beyond Air aims to explore new avenues for treatment, fostering a healthier future for patients worldwide.
Contact Information for Inquiries
For additional details or inquiries, interested parties may contact:
Corey Davis, Ph.D.
LifeSci Advisors, LLC
Cdavis@lifesciadvisors.com
(212) 915-2577
Frequently Asked Questions
What is the date of Beyond Air's financial report?
Beyond Air will report its financial results for Q2 on November 11, 2024.
How can I join the conference call?
You can join the call by dialing 1-877-407-0784 for domestic calls and 1-201-689-8560 for international calls, using Conference ID: 13749670.
What innovative technology does Beyond Air use?
Beyond Air utilizes the LungFit® platform, a system for the generation and delivery of nitric oxide for treating respiratory diseases.
Is there a way to access the webcast?
Yes, you can access the live webcast on Beyond Air's website under the Events section or through a direct link provided in their announcements.
Who can I contact for more information?
You can reach out to Corey Davis at LifeSci Advisors via the email Cdavis@lifesciadvisors.com or call (212) 915-2577.
